TrialBMJ open respiratory research2021

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort.

Geertje de Boer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.